Vivo Bio Tech Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Vivo Bio Tech Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
28.38% Fall from 52W High
-5.3
TTM PE Ratio
Below industry Median
23.7
Price to Book Ratio
Low in industry
1.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-5.1
RSI
RSI is mid-range
37.9
MFI
MFI strongly Oversold
15.3

Vivo Bio Tech Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Vivo Bio Tech Ltd shareholding Pattern

Promoter
42.1%
Public
57.9%
Promoter
42.1%
Public
57.9%
Promoter
42.1%
Public
57.9%
Promoter
42.1%
Public
57.9%
Promoter
42.1%
Public
57.9%
Promoter
42.2%
Public
57.8%

Vivo Bio Tech Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
3
Bearish Moving Averages
13
5Day EMA
41.20
10Day EMA
41.70
12Day EMA
41.80
20Day EMA
42.40
26Day EMA
42.70
50Day EMA
43.00
100Day EMA
41.90
200Day EMA
39.10
5Day SMA
41.20
10Day SMA
41.70
20Day SMA
42.60
30Day SMA
43.40
50Day SMA
43.50
100Day SMA
43.20
150Day SMA
40.00
200Day SMA
38.00
Delivery & Volume
Resistance & Support
40.81
Pivot
Resistance
First Resistance
42.31
Second Resistance
44.52
Third Resistance
46.02
Support
First Support
38.60
Second support
37.10
Third Support
34.89
Relative Strength Index
37.91
Money Flow Index
15.26
MACD
-0.84
MACD Signal
-0.67
Average True Range
2.55
Average Directional Index
12.98
Rate of Change (21)
-10.99
Rate of Change (125)
21.77
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Alpa Laboratories Ltd.
187.26
59.35
115
Panacea Biotec Ltd.
827.19
115.15
202.2
Vivo Bio Tech Ltd.
-
-
-
Bharat Immunological & Biologicals Corporation Ltd.
-
-
-
Genomic Valley Biotech Ltd.
-
-
-
Shree Ganesh Bio-Tech (India) Ltd.
-
-
-
Advanced Enzyme Technologies Ltd.
4168.24
265.85
425.1

Vivo Bio Tech Ltd Company background

Founded in: 1987
Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development discovery services to pharmaceutical biotech companies worldwide in accordance with OECD, AAALAC IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics toxicokinetic studies etc. Their experienced talented scientists offer advice on defining drug development paths tailored to specific molecules.The Company stands as a premier and primary provider of SPF lab animals in India. It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences. The Company serves as an authorized distributor of lab animal diets from Special Diets Services (UK) in India. It pioneered the commercial distribution of SPF guinea pigs, sourcing breeders from Elm Hill Labs (USA). Employing topquality SPF breed in their inhouse lab animals, the Company upholds excellence in all pre clinical studies. Their comprehensive services span a wide array of preclinical toxicology disciplines, encompassing Invitro and Invivo studies, analytical chemistry studies, bioanalytical studies, and physicochemical studies. Moreover, the Company boasts supplementary satellite facilities situated in Pregnapur Village, Siddipet District, Hyderabad, Telangana. The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Invitro Services offers solutions for pharmacologic, toxicological bio analytical investigations in drug discovery development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by the scientists.The Invivo Services group at Vivo Bio Tech provides both nonregulatory and regulatory IND enabling pre clinical development services. We are capable of screening evaluating molecules for various pharmacological therapeutic properties. Specifically for oncology, scientists provide design development of xenograft models for evaluation of anticancer agents. Further, scientists customize invivo DMPK studies to help drug candidate in both rodent and nonrodent animal models.Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started inhouse breeding of Specific Pathogen Free rodents.The Company partnered Cyagen Biosciences to access genomic technologies in 2016. It commenced breeding and distribution of SPF guinea pigs in 2017. The Company acquired 100% shareholding in M/s. Donakanti Consulting Services Private Ltd on 17 April, 2019. It received ISO 9001:2015 Certification for Quality Management System. The Company completed NGCMA OECD GLP Surveillance and Scope Extension with the introduction of inhalational studies in 2019.The Company transformed from an animal breeding and distributing company into a full service CRO with interest in Invitro, Invivo, EcoTox, Analytical, Bio Analytical and Physchem, ADME and PKPD studies in 2021.
Read More

Vivo Bio Tech Ltd FAQs

You can easily buy Vivo Bio Tech Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage